A novel knitted scaffold made of microfiber/nanofiber core–sheath yarns for tendon tissue engineering
Source abstract
Abstract
Tendon injury is common in sports and other rigorous activities, which may result in dysfunction and disability. Recently, scaffolds with a knitted structure have been widely applied for tendon tissue engineering. The purpose of this study was to fabricate a novel knitted tendon scaffold made of microfiber/nanofiber core-sheath yarns and evaluate the biocompatibility and the effect of tenogenic differentiation and tendon tissue regeneration in vitro and in vivo. Poly(ε-caprolactone) (PCL) microfibers, PCL microfibers-PCL nanofibers (PCL-PCL) and PCL microfiber-silk fibroin/poly(l-lactic acid-co-ε-caprolactone) nanofiber (SF/PLCL) core-sheath yarns were fabricated and then knitted with an automatic knitting machine to produce PCL, PCL-PCL and PCL-SF/PLCL fabric scaffolds. The characterization of the scaffolds was performed by using scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy and an universal mechanical instrument. The in vitro experiment showed that rabbit bone marrow stem cells seeded on the scaffolds exhibited an elongated morphology and proliferated better in the PCL-SF/PLCL group, as compared to the PCL and PCL-PCL groups. Moreover, the PCL-SF/PLCL scaffold promoted the tenogenic differentiation of the cells for the highest expression levels of the tendon-related genes through down-regulating p-ERK1/2 expression among the three groups. Furthermore, the in vivo study in a rabbit patellar defect model demonstrated that the PCL-SF/PLCL scaffold could enhance the tissue regeneration and remodeling process as indicated by the better structural and biomechanical properties according to the results of histology, immunohistochemistry, transmission electron microscope examination and biomechanical tests. Therefore, the PCL-SF/PLCL scaffold is proved to be a promising biomaterial for tendon tissue engineering and a potential candidate for clinical treatment of tendon injury in the future.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tendon Structure and Treatment · Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Sports Medicine
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai
China
State Key Laboratory for Modification of Chemical Fibers and Polymer Materials
College of Chemistry
Chemical Engineering and Biotechnology
Donghua University
Funding
National Basic Research Program of China · National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (36)
Show source-provided references
1. Dams · Knee Surg. Sports Traumatol. Arthrosc. · 2019 · 27 · 275410.1007/s00167-018-5049-5 ↗
2. Liu · Tissue Eng., Part B · 2011 · 17 · 16510.1089/ten.teb.2010.0662 ↗
3. Galatz · J. Orthop. Res. · 2015 · 33 · 82310.1002/jor.22853 ↗
4. Andarawis-Puri · J. Orthop. Res. · 2015 · 33 · 78010.1002/jor.22869 ↗
5. Chen · Biomaterials · 2010 · 31 · 943810.1016/j.biomaterials.2010.08.011 ↗
6. Zheng · Acta Biomater. · 2017 · 51 · 31710.1016/j.actbio.2017.01.041 ↗
7. Tang · Acta Bioeng. Biomech. · 2018 · 20 · 77
8. Zhao · J. Mater. Chem. B · 2019 · 7 · 220110.1039/C8TB02759E ↗
9. Ouyang · J. Biomed. Mater. Res., Part B · 2005 · 75 · 26410.1002/jbm.b.30281 ↗
10. Sahoo · Tissue Eng. · 2006 · 12 · 9110.1089/ten.2006.12.91 ↗
11. Cai · Int. J. Nanomed. · 2018 · 13 · 348110.2147/IJN.S165633 ↗
12. Zhang · Biomaterials · 2015 · 53 · 71610.1016/j.biomaterials.2015.02.051 ↗
13. Gu · Colloids Surf., B · 2018 · 161 · 33110.1016/j.colsurfb.2017.10.066 ↗
14. Wu · Mater. Sci. Eng., C · 2020 · 106 · 11026810.1016/j.msec.2019.110268 ↗
15. Wang · Acta Biomater. · 2011 · 7 · 63410.1016/j.actbio.2010.09.011 ↗
16. Cai · Artif. Organs · 2018 · 42 · 108610.1111/aor.13298 ↗
17. Xu · Biomaterials · 2014 · 35 · 276010.1016/j.biomaterials.2013.12.042 ↗
18. Chen · Tissue Eng., Part A · 2011 · 17 · 203710.1089/ten.tea.2010.0492 ↗
19. Cohen · Am. J. Sports Med. · 2006 · 34 · 36210.1177/0363546505280428 ↗
20. Chen · Biomaterials · 2008 · 29 · 368310.1016/j.biomaterials.2008.05.017 ↗
21. Mallakpour · Polymer · 2016 · 89 · 9410.1016/j.polymer.2016.02.038 ↗
22. Khan · Pharmaceutics · 2019 · 11 · 38610.3390/pharmaceutics11080386 ↗
23. Deng · Biomaterials · 2014 · 35 · 880110.1016/j.biomaterials.2014.06.058 ↗
24. Svensson · Acta Biomater. · 2017 · 50 · 29310.1016/j.actbio.2017.01.006 ↗
25. Stevens · Science · 2005 · 310 · 113510.1126/science.1106587 ↗
26. Lin · Acta Biomater. · 2018 · 70 · 110.1016/j.actbio.2018.01.012 ↗
27. Zhang · Macromol. Mater. Eng. · 2013 · 298 · 56510.1002/mame.201200038 ↗
28. Zhang · Polym. Degrad. Stab. · 2011 · 96 · 226610.1016/j.polymdegradstab.2011.08.011 ↗
29. Zhang · Biomater. Sci. · 2018 · 6 · 41810.1039/C7BM01044C ↗
30. Wang · FASEB J. · 2018 · 32 · 480410.1096/fj.201701384R ↗
31. Liu · FASEB J. · 2017 · 31 · 380010.1096/fj.201601181R ↗
32. Cai · J. Mater. Chem. B · 2018 · 6 · 573810.1039/C8TB01310A ↗
33. Yang · Colloids Surf., B · 2014 · 122 · 27010.1016/j.colsurfb.2014.06.061 ↗
34. Jiang · Artif. Organs · 2016 · 40 · 38510.1111/aor.12571 ↗
35. No · Adv. Mater. · 2020 · 32 · e190451110.1002/adma.201904511 ↗
36. Wang · Tissue Eng., Part A · 2017 · 23 · 75010.1089/ten.tea.2016.0447 ↗